Related Experiment Video
Updated: Aug 3, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
[Kidney tumors in childhood]
1Department of Pathology, Children's Memorial Hospital, Annex Bldg, Room A204, 2373 N. Lincold Avenue, Chicago, IL 60614, USA.
Abstract:
Types of renal tumors arising in children are different from those occurring in adults. Nephroblastoma is the most common (85%) with a clinical outcome which has dramatically improved in the last 30 years. Current classifications are aimed at better adaptation of treatment to each individual case, reducing iatrogenic complications without impairing total cure. Amongst entities which have been recently described or are better known we can find juvenile carcinoma associated with Xp11.2 translocation, renal medullary carcinoma, metanephric tumors, etc. Role of molecular cytogenetics is increasing for classification (and treatment) and this should always be kept in mind when dealing a fresh specimen of childhood renal tumor.
Insights
Pediatric renal tumors differ from adult types, with Wilms tumor being most common. Advances in classification and molecular cytogenetics improve treatment and outcomes for childhood kidney cancers.
Area of Science:
- Pediatric Oncology
- Nephrology
- Cancer Genetics
Context:
- Childhood renal tumors exhibit distinct characteristics compared to adult counterparts.
- Nephroblastoma (Wilms tumor) accounts for the vast majority (85%) of pediatric kidney tumors.
- Significant improvements in clinical outcomes for these tumors have been observed over the past three decades.
Purpose:
- To highlight the unique nature of pediatric renal tumors.
- To emphasize the evolving role of classification systems in tailoring treatment.
- To underscore the importance of molecular cytogenetics in diagnosis and management.
Summary:
- Pediatric renal tumors are distinct from adult types, with nephroblastoma being the most prevalent.
- Modern classification strategies aim to personalize treatment, minimize complications, and ensure curative outcomes.
- Emerging entities like Xp11.2 translocation juvenile carcinoma and renal medullary carcinoma require specialized diagnostic approaches.
- Molecular cytogenetics plays an increasingly crucial role in the classification and treatment of childhood renal tumors.
Impact:
- Facilitates more precise diagnosis and tailored treatment strategies for pediatric renal tumors.
- Contributes to reducing iatrogenic complications while maintaining high cure rates.
- Enhances the understanding and management of rare and newly described pediatric kidney tumor entities.
- Promotes the integration of advanced molecular techniques in routine pathology practice for childhood renal tumors.
Related Concept Videos
Kidney Structure
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Nephrons
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

